Azienda USL di Imola - Ospedale di Imola

Imola 40026

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed